Skip to content

13F-HR filed by GILEAD SCIENCES, INC.

GILEAD SCIENCES, INC. filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-05 22:57:42 UTC, with 5 holding rows worth $1,463,841,605.

Accession
0001123292-26-001479
Filed
2026-11-06
Accepted by EDGAR
Ingested
Source
EDGAR daily index

Original filing

13F report for Q3 2026

A holdings report, 5 entries on the cover page, a total value of $1,463,841,605 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,463,841,605 with VALUE read as dollars as filed, 13F file number 028-25078. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ARCUS BIOSCIENCES INC03969F109COM31,424,760$811,701,551dollars as filed
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR16,707,477$501,284,604dollars as filed
ASSEMBLY BIOSCIENCES INC045396207COMMON STOCK4,977,089$116,911,821dollars as filed
KYVERNA THERAPEUTICS INC501976104COMMON STOCK4,126,119$28,057,609dollars as filed
Xilio Therapeutics Inc.98422T100COM650,389$5,886,020dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001123292-26-001479this filing2026-11-06